111 related articles for article (PubMed ID: 7921926)
1. Therapeutical effect of activated human macrophages on a human tumor line growing in nude mice.
Ben-Efraim S; Tak C; Romijn JC; Fieren MJ; Bonta IL
Med Oncol; 1994; 11(1):7-12. PubMed ID: 7921926
[TBL] [Abstract][Full Text] [Related]
2. Activity of human peritoneal macrophages against a human tumor: role of tumor necrosis factor-alpha, PGE2 and nitrite, in vitro studies.
Ben-Efraim S; Tak C; Fieren MJ; Romijn JC; Beckmann I; Bonta IL
Immunol Lett; 1993 Jul; 37(1):27-33. PubMed ID: 8225404
[TBL] [Abstract][Full Text] [Related]
3. Modulation of antitumour activity of macrophages by regulation of eicosanoids and cytokine production.
Ben-Efraim S; Bonta IL
Int J Immunopharmacol; 1994; 16(5-6):397-9. PubMed ID: 7927985
[TBL] [Abstract][Full Text] [Related]
4. In vivo exposure to Porphyromonas gingivalis up-regulates nitric oxide but suppresses tumour necrosis factor-alpha production by cultured macrophages.
Frolov I; Houri-Hadad Y; Soskolne A; Shapira L
Immunology; 1998 Mar; 93(3):323-8. PubMed ID: 9640241
[TBL] [Abstract][Full Text] [Related]
5. Activation in vitro of peritoneal macrophages by a nocardia fraction.
Ben-Efraim S; Rashid G; Gittel H; Tax C; Ciorbaru RB
Anticancer Res; 1994; 14(2A):449-52. PubMed ID: 8017846
[TBL] [Abstract][Full Text] [Related]
6. Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines.
Belldegrun A; Tso CL; Sakata T; Duckett T; Brunda MJ; Barsky SH; Chai J; Kaboo R; Lavey RS; McBride WH
J Natl Cancer Inst; 1993 Feb; 85(3):207-16. PubMed ID: 8423625
[TBL] [Abstract][Full Text] [Related]
7. Induction of macrophage antitumor activity by a mycobacterial fraction. In vivo and in vitro studies.
Rashid G; Gittel H; Ben-Efraim S
Anticancer Res; 1994; 14(3A):1083-7. PubMed ID: 8074454
[TBL] [Abstract][Full Text] [Related]
8. Activated peritoneal macrophages inhibit the proliferation of rat ascites hepatoma AH-130 cells via the production of tumor necrosis factor-alpha and nitric oxide.
Maekawa H; Iwabuchi K; Nagaoka I; Watanabe H; Kamano T; Tsurumaru M
Inflamm Res; 2000 Oct; 49(10):541-7. PubMed ID: 11089907
[TBL] [Abstract][Full Text] [Related]
9. IFN-gamma inhibits the suppressive effects of PGE2 on the production of tumor necrosis factor-alpha by mouse macrophages.
Kim JG; Hahn YS
Immunol Invest; 2000 Aug; 29(3):257-69. PubMed ID: 10933609
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 inhibits the release of tumor necrosis factor-alpha, rather than interleukin 1 beta, from human macrophages.
Fieren MW; van den Bemd GJ; Ben-Efraim S; Bonta IL
Immunol Lett; 1992 Jan; 31(1):85-90. PubMed ID: 1548034
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2.
Strassmann G; Patil-Koota V; Finkelman F; Fong M; Kambayashi T
J Exp Med; 1994 Dec; 180(6):2365-70. PubMed ID: 7525853
[TBL] [Abstract][Full Text] [Related]
12. Bovine serum albumin preparations enhance in vitro production of tumor necrosis factor alpha by murine macrophages.
Zheng ZM; Specter SC; Lancz G
Immunol Invest; 1995 Aug; 24(5):737-56. PubMed ID: 8543338
[TBL] [Abstract][Full Text] [Related]
13. Involvement of protein kinases in the potentiation of lipopolysaccharide-induced inflammatory mediator formation by thapsigargin in peritoneal macrophages.
Chen BC; Hsieh SL; Lin WW
J Leukoc Biol; 2001 Feb; 69(2):280-8. PubMed ID: 11272279
[TBL] [Abstract][Full Text] [Related]
14. Haemorrhagic shock in mice--intracellular signalling and immunomodulation of peritoneal macrophages' LPS response.
Rani M; Husain B; Lendemans S; Schade FU; Flohé S
Immunobiology; 2006; 211(9):711-9. PubMed ID: 17015146
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts.
van Dijk J; Uemura H; Beniers AJ; Peelen WP; Zegveld ST; Fleuren GJ; Warnaar SO; Oosterwijk E
Int J Cancer; 1994 Jan; 56(2):262-8. PubMed ID: 8314310
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study on influence of bone marrow mesenchymal stem cells on activation and function of mouse peritoneal macrophages].
Yang YW; Bai H; Wang CB; Lin M; Wu LQ
Zhonghua Xue Ye Xue Za Zhi; 2008 Aug; 29(8):540-3. PubMed ID: 19112918
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor is required for the priming of peritoneal macrophages by trehalose dimycolate.
Oswald IP; Dozois CM; Fournout S; Petit JF; Lemaire G
Eur Cytokine Netw; 1999 Dec; 10(4):533-40. PubMed ID: 10586120
[TBL] [Abstract][Full Text] [Related]
18. [Studies on anti-tumor activity of tumor necrosis factor alpha against human renal cell carcinoma cells heterotransplanted into nude mice].
Shibayama T; Tachibana M; Tazaki H; Nakamura K
Nihon Hinyokika Gakkai Zasshi; 1991 Oct; 82(10):1611-9. PubMed ID: 1770700
[TBL] [Abstract][Full Text] [Related]
19. [Differential growth inhibition of mycobacteria by interferon-gamma-or tumor necrosis factor-alpha-treated murine peritoneal macrophages].
Sato K; Tomioka H; Saito H
Kekkaku; 1996 Nov; 71(11):607-14. PubMed ID: 8958673
[TBL] [Abstract][Full Text] [Related]
20. Antitumoral effects of lipopolysaccharides, tumor necrosis factor, interferon and activated macrophages: synergism and tissue distribution.
Chokri M; Freudenberg M; Galanos C; Poindron P; Bartholeyns J
Anticancer Res; 1989; 9(4):1185-90. PubMed ID: 2817800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
